AwardTape · Defense awards · Research and development · Defense systems R&D · HDTRA124C0008
HDTRA124C0008: $5.6M definitive contract to Ministry of Defence
Ministry of Defence holds a definitive contract from Defense Threat Reduction Agency with $5.6M obligated since Oct 2023, against a ceiling of $8.4M. Latest action May 18, 2026.
Generation of a novel antibody-antibiotic conjugate as a combination therapy platform to treat melioidosis or plague.
| PIID | HDTRA124C0008 |
|---|---|
| Type | definitive contract |
| Company | Ministry of Defence |
| Agency | Defense Threat Reduction Agency |
| Contracting office | DEFENSE THREAT REDUCTION AGENCY |
| Category | Research and development · Defense systems R&D |
| PSC | AC32 NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $5.6M |
| Total obligated (lifetime) | $5.6M |
| Ceiling (base and all options) | $8.4M |
| Base date | Jun 6, 2024 |
| Latest action | May 18, 2026 |
| End date | Dec 9, 2029 |
| Actions since Oct 2023 | 10 |
| Pricing | Cost plus fixed fee |
| Competition | Full and open competition |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial